[go: up one dir, main page]

AR038624A1 - Un procedimiento para preparar un derivado de fenilalanina e intermediarios del mismo - Google Patents

Un procedimiento para preparar un derivado de fenilalanina e intermediarios del mismo

Info

Publication number
AR038624A1
AR038624A1 ARP030100662A ARP030100662A AR038624A1 AR 038624 A1 AR038624 A1 AR 038624A1 AR P030100662 A ARP030100662 A AR P030100662A AR P030100662 A ARP030100662 A AR P030100662A AR 038624 A1 AR038624 A1 AR 038624A1
Authority
AR
Argentina
Prior art keywords
formula
compound
same
procedure
symbols
Prior art date
Application number
ARP030100662A
Other languages
English (en)
Inventor
Isao Inoue
Toru Kuroda
Ryuzo Yoshioka
Original Assignee
Tanabe Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanabe Seiyaku Co filed Critical Tanabe Seiyaku Co
Publication of AR038624A1 publication Critical patent/AR038624A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C233/81—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C07C233/82—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/87—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom of a carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/02—Preparation of carboxylic acid amides from carboxylic acids or from esters, anhydrides, or halides thereof by reaction with ammonia or amines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02—Boron compounds
    • C07F5/025—Boronic and borinic acid compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Un procedimiento para preparar un derivado de fenilalanina de la fórmula (1) en donde X1 es un átomo de halógeno; X2 es un átomo de halógeno; Q es un grupo de la fórmula -CH2 ó -(CH2)2 e Y es un grupo alquilo inferior, ó una sal farmacéuticamente aceptable del mismo, dicho procedimiento comprende condensar un compuesto de la fórmula (2) en donde CO2R es un grupo carboxilo protegido y los otros símbolos son los mismos que se definieron más arriba, ó una sal del mismo, con un compuesto de la fórmula (3) en donde los símbolos son los mismos que se definieron más arriba, una sal ó un derivado reactivo del mismo para dar un compuesto de la fórmula (4) en donde los símbolos son los mismos que se definieron más arriba, y eliminar el grupo protector del grupo carboxilo protegido del compuesto (4), y de ser necesario, seguido por la conversión del compuesto resultante en una sal farmacéuticamente aceptable. Intermediario de fórmula (2), procedimiento para su preparación y compuesto intermediario útil en este último.
ARP030100662A 2002-02-28 2003-02-28 Un procedimiento para preparar un derivado de fenilalanina e intermediarios del mismo AR038624A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2002052605 2002-02-28

Publications (1)

Publication Number Publication Date
AR038624A1 true AR038624A1 (es) 2005-01-19

Family

ID=27764341

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP030100662A AR038624A1 (es) 2002-02-28 2003-02-28 Un procedimiento para preparar un derivado de fenilalanina e intermediarios del mismo

Country Status (21)

Country Link
US (1) US7476758B2 (es)
EP (1) EP1478619B1 (es)
KR (1) KR100681224B1 (es)
CN (2) CN100522930C (es)
AR (1) AR038624A1 (es)
AT (1) ATE495147T1 (es)
AU (1) AU2003208618B2 (es)
BR (1) BR0308027A (es)
CA (1) CA2476022C (es)
DE (1) DE60335704D1 (es)
ES (1) ES2359302T3 (es)
IL (1) IL163429A (es)
MX (1) MXPA04008359A (es)
MY (1) MY140707A (es)
NO (1) NO331001B1 (es)
NZ (1) NZ534957A (es)
PL (1) PL211046B1 (es)
RU (1) RU2280641C2 (es)
TW (1) TWI327996B (es)
WO (1) WO2003072536A1 (es)
ZA (1) ZA200406747B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI312347B (en) 2001-02-08 2009-07-21 Eisai R&D Man Co Ltd Bicyclic nitrogen-containing condensed ring compounds
HUP0401292A3 (en) 2001-04-27 2011-01-28 Eisai R & D Man Co Pyrazolo[1,5-a]pyridines, pharmaceutical compositions containing the same and process for preparation thereof
AU2003265398A1 (en) * 2002-08-09 2004-02-25 Transtech Pharma, Inc. Aryl and heteroaryl compounds and methods to modulate coagulation
SI1555265T1 (sl) * 2002-10-22 2009-06-30 Eisai R&D Man Co Ltd 7-fenil pirazolopiridinske spojine
US7176216B2 (en) 2002-10-22 2007-02-13 Eisai Co., Ltd. 7-phenylpyrazolopyridine compounds
US7208601B2 (en) 2003-08-08 2007-04-24 Mjalli Adnan M M Aryl and heteroaryl compounds, compositions, and methods of use
WO2005014532A1 (en) * 2003-08-08 2005-02-17 Transtech Pharma, Inc. Aryl and heteroaryl compounds, compositions and methods of use
DE602006019731D1 (de) 2005-06-09 2011-03-03 Ucb Pharma Sa 2,6-chinolinderivate sowie verfahren zu ihrer herstellung und verwendung als arzneimittel
MY152687A (en) 2008-04-15 2014-10-31 Eisai R&D Man Co Ltd 3-phenylpyrazolo[5,1-b]thiazole compound
AR078521A1 (es) 2009-10-08 2011-11-16 Eisai R&D Man Co Ltd Compuesto pirazolotiazol
EA201290165A1 (ru) 2009-10-21 2012-11-30 Глаксо Груп Лимитед Способ получения производного фенилаланина
AU2019373242B2 (en) 2018-10-30 2023-07-13 Gilead Sciences, Inc. Compounds for inhibition of alpha 4 beta 7 integrin
US11174256B2 (en) 2018-10-30 2021-11-16 Gilead Sciences, Inc. Imidazopyridine derivatives
HRP20250191T1 (hr) 2018-10-30 2025-04-11 Gilead Sciences, Inc. Derivati 3-(kinolin-8-il)-1,4-dihidropirido[3,4-d]pirimidin-2,4-diona kao inhibitori alfa4beta7 integrina za liječenje upalnih bolesti
JP7189369B2 (ja) 2018-10-30 2022-12-13 ギリアード サイエンシーズ， インコーポレイテッド アルファ４β７インテグリンの阻害のための化合物
EP4013499A1 (en) 2019-08-14 2022-06-22 Gilead Sciences, Inc. Compounds for inhibition of alpha 4 beta 7 integrin

Family Cites Families (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU570710B2 (en) * 1983-08-12 1988-03-24 Takeda Chemical Industries Ltd. 4-oxo-2, 3, 4, 5-tetrahydro-1, 5-benzoxazepine derivatives
DE3508251A1 (de) 1985-03-08 1986-09-11 Merck Patent Gmbh, 6100 Darmstadt Dipeptide
GB8625941D0 (en) * 1986-10-30 1986-12-03 Sandoz Ltd Substituted alpha-amino acids
NZ228855A (en) 1988-04-25 1992-08-26 Hoffmann La Roche Tyrosine analogues and peptides containing them especially cholecystokinin (cck) analogues
JP2868914B2 (ja) 1991-03-04 1999-03-10 日本ケミファ株式会社 α−アミノ酸誘導体
US5294632A (en) 1991-05-01 1994-03-15 Ciba-Geigy Corporation Phosphono/biaryl substituted dipetide derivatives
US5455260A (en) * 1993-05-21 1995-10-03 Rhone-Poulenc Rorer Pharmaceuticals Inc. Aliphatic amino bis-aryl squalene synthase inhibitors
US5780498A (en) * 1993-11-01 1998-07-14 Ciba-Geigy Japan Limited Endothelin receptor antagonists
US5432186A (en) * 1993-11-16 1995-07-11 Ciba-Geigy Corporation Cyclic amino acid derivatives
IL112759A0 (en) * 1994-02-25 1995-05-26 Khepri Pharmaceuticals Inc Novel cysteine protease inhibitors
CA2183767A1 (en) * 1994-03-28 1995-10-05 Thomas Fruh Antagonists of endothelin receptors
US5505244A (en) * 1994-08-08 1996-04-09 Thumann; Pierce A. Retractable covering for a door opening
EP0798291B1 (en) 1994-12-14 2002-09-11 Santen Pharmaceutical Co., Ltd. Novel 1,3-dialkylurea derivatives
US6306840B1 (en) * 1995-01-23 2001-10-23 Biogen, Inc. Cell adhesion inhibitors
CA2218716A1 (en) * 1995-04-21 1996-10-24 Novartis Ag N-aroylamino acid amides as endothelin inhibitors
GB9518553D0 (en) 1995-09-11 1995-11-08 Fujisawa Pharmaceutical Co New urea derivatives processes for the preparation thereof and pharmaceutical composition comprising the same
JPH0987291A (ja) 1995-09-26 1997-03-31 Wakamoto Pharmaceut Co Ltd 新規なアラニン誘導体
JPH11512702A (ja) 1995-09-28 1999-11-02 日本チバガイギー株式会社 エンドセリンレセプターのアンタゴニスト
IT1277737B1 (it) 1995-12-28 1997-11-12 Zambon Spa Derivati tiolici ad attivita' inibitrice delle metallopeptidasi
US5849293A (en) * 1996-01-11 1998-12-15 Cornell Research Foundation, Inc. Use of human transferrin in controlling insulin levels
FR2745571B1 (fr) * 1996-03-04 1998-06-19 Inst Nat Sante Rech Med Nouveaux derives soufres comportant une liaison amide, leur procede de preparation, leur application a titre de medicaments, et les compositions pharmaceutiques les renfermant
DK0906333T3 (da) 1996-04-24 2001-11-12 Medivir Uk Ltd Substrater og inhibitorer for proteolytiske enzymer
JPH1036587A (ja) * 1996-07-24 1998-02-10 Chisso Corp 二軸延伸ポリプロピレンフィルム
SE9700934D0 (sv) * 1997-03-14 1997-03-14 Astra Ab New formulation
US6221888B1 (en) * 1997-05-29 2001-04-24 Merck & Co., Inc. Sulfonamides as cell adhesion inhibitors
EP1001764A4 (en) 1997-05-29 2005-08-24 Merck & Co Inc HETEROCYCLIC AMIDE COMPOUNDS AS INHIBITORS OF CELL ADHESION
US6291511B1 (en) * 1997-05-29 2001-09-18 Merck & Co., Inc. Biarylalkanoic acids as cell adhesion inhibitors
WO1998054207A1 (en) * 1997-05-30 1998-12-03 Celltech Therapeutics Limited Anti-inflammatory tyrosine derivatives
US6127341A (en) * 1997-06-20 2000-10-03 Novo Nordisk A/S Compounds with growth hormone releasing properties
DE69818049T2 (de) * 1997-06-23 2004-07-15 Tanabe Seiyaku Co., Ltd. Inhibitoren der alpha4-beta1 vermittelten zelladhäsion
CA2290750A1 (en) 1997-07-31 1999-02-11 Elan Pharmaceuticals, Inc. 4-amino-phenylalanine type compounds which inhibit leukocyte adhesion mediated by vla-4
NZ502582A (en) 1997-07-31 2002-07-26 American Home Prod Substituted phenylalanine type compounds which inhibit leukocyte adhesion mediated by VLA-4
IL133635A0 (en) 1997-07-31 2001-04-30 Elan Pharm Inc Benzyl compounds which inhibit leukocyte adhesion mediated by vla-4
KR20010022423A (ko) 1997-07-31 2001-03-15 진 엠. 듀발 Ｖｌａ-4에 의해 매개되는 백혈구 부착을 억제하는 화합물
KR20010022412A (ko) 1997-07-31 2001-03-15 진 엠. 듀발 Ｖｌａ-4에 의해 매개되는 백혈구 유착을 억제하는디펩티드 화합물
US6489300B1 (en) * 1997-07-31 2002-12-03 Eugene D. Thorsett Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4
KR20010022406A (ko) 1997-07-31 2001-03-15 진 엠. 듀발 Ｖｌａ-4에 의해 매개되는 백혈구 유착을 억제하는디펩타이드 및 관련 화합물
AR016133A1 (es) 1997-07-31 2001-06-20 Wyeth Corp Compuesto de carbamiloxi que inhiben la adhesion de leucocitos mediada por vla-4, compuestos que son prodrogas de dichos compuestos, composicionfarmaceutica, metodo para fijar vla-4 a una muestra biologica, metodo para el tratamiento de una condicion inflamatoria
US6229011B1 (en) * 1997-08-22 2001-05-08 Hoffman-La Roche Inc. N-aroylphenylalanine derivative VCAM-1 inhibitors
US6455550B1 (en) * 1997-08-22 2002-09-24 Hoffmann-La Roche Inc. N-alkanoylphenylalanine derivatives
US5988980A (en) * 1997-09-08 1999-11-23 General Electric Company Blade assembly with splitter shroud
US6069163A (en) * 1997-10-21 2000-05-30 Merck & Co., Inc. Azapeptide acids as cell adhesion inhibitors
US6191171B1 (en) * 1997-11-20 2001-02-20 Merck & Co., Inc. Para-aminomethylaryl carboxamide derivatives
US6090841A (en) * 1997-11-21 2000-07-18 Merck & Co., Inc. Substituted pyrrole derivatives as cell adhesion inhibitors
AU750175B2 (en) * 1997-11-24 2002-07-11 Merck & Co., Inc. Cyclic amino acid derivatives as cell adhesion inhibitors
US6645939B1 (en) * 1997-11-24 2003-11-11 Merck & Co., Inc. Substituted β-alanine derivatives as cell adhesion inhibitors
US6197794B1 (en) * 1998-01-08 2001-03-06 Celltech Therapeutics Limited Phenylalanine derivatives
KR20010033963A (ko) 1998-01-19 2001-04-25 오미야 히사시 아폽토시스 유도가능 물질
MY153569A (en) * 1998-01-20 2015-02-27 Mitsubishi Tanabe Pharma Corp Inhibitors of ?4 mediated cell adhesion
US6329372B1 (en) * 1998-01-27 2001-12-11 Celltech Therapeutics Limited Phenylalanine derivatives
WO1999043642A1 (en) * 1998-02-26 1999-09-02 Celltech Therapeutics Limited Phenylalanine derivatives as inhibitors of alpha4 integrins
US6521626B1 (en) * 1998-03-24 2003-02-18 Celltech R&D Limited Thiocarboxamide derivatives
GB9811159D0 (en) * 1998-05-22 1998-07-22 Celltech Therapeutics Ltd Chemical compounds
GB9812088D0 (en) 1998-06-05 1998-08-05 Celltech Therapeutics Ltd Chemical compounds
WO1999064395A1 (en) 1998-06-11 1999-12-16 Merck & Co., Inc. Heterocyclic amide compounds as cell adhesion inhibitors
US6685617B1 (en) * 1998-06-23 2004-02-03 Pharmacia & Upjohn Company Inhibitors of α4β1 mediated cell adhesion
NL1009753C2 (nl) 1998-07-28 2000-02-01 Royalty Bugaboo S A R L Buggy.
DE69915692T2 (de) 1998-12-22 2005-02-10 Tanabe Seiyaku Co., Ltd. Inhibitoren der alpha-4 beta-1 vermittelten zelladhäsion
WO2000043369A1 (en) 1999-01-22 2000-07-27 Elan Pharmaceuticals, Inc. Compounds which inhibit leukocyte adhesion mediated by vla-4
GB2354440A (en) 1999-07-20 2001-03-28 Merck & Co Inc Aryl amides as cell adhesion inhibitors
AU6903200A (en) * 1999-08-16 2001-03-13 Merck & Co., Inc. Heterocycle amides as cell adhesion inhibitors
AU6909300A (en) * 1999-08-20 2001-03-19 Merck & Co., Inc. Substituted ureas as cell adhesion inhibitors
WO2001021584A1 (en) * 1999-09-24 2001-03-29 Genentech, Inc. Tyrosine derivatives
MY129000A (en) * 2000-08-31 2007-03-30 Tanabe Seiyaku Co INHIBITORS OF a4 MEDIATED CELL ADHESION
US6489511B1 (en) * 2001-08-16 2002-12-03 Eastman Kodak Company Azomethine compound manufacture

Also Published As

Publication number Publication date
PL371386A1 (en) 2005-06-13
TWI327996B (en) 2010-08-01
AU2003208618B2 (en) 2008-06-19
HK1069382A1 (en) 2005-05-20
CA2476022A1 (en) 2003-09-04
NO20044087L (no) 2004-09-27
TW200303854A (en) 2003-09-16
US7476758B2 (en) 2009-01-13
WO2003072536A1 (en) 2003-09-04
IL163429A (en) 2012-07-31
KR100681224B1 (ko) 2007-02-09
CN1817853A (zh) 2006-08-16
BR0308027A (pt) 2004-12-28
PL211046B1 (pl) 2012-04-30
KR20040091665A (ko) 2004-10-28
AU2003208618A1 (en) 2003-09-09
DE60335704D1 (de) 2011-02-24
RU2280641C2 (ru) 2006-07-27
RU2004128935A (ru) 2006-02-20
ATE495147T1 (de) 2011-01-15
EP1478619A1 (en) 2004-11-24
CN1646482A (zh) 2005-07-27
MY140707A (en) 2010-01-15
CN100480233C (zh) 2009-04-22
ES2359302T3 (es) 2011-05-20
ZA200406747B (en) 2005-08-31
NZ534957A (en) 2006-11-30
MXPA04008359A (es) 2004-11-26
CA2476022C (en) 2008-07-15
CN100522930C (zh) 2009-08-05
US20050165107A1 (en) 2005-07-28
NO331001B1 (no) 2011-09-05
EP1478619B1 (en) 2011-01-12

Similar Documents

Publication Publication Date Title
AR038624A1 (es) Un procedimiento para preparar un derivado de fenilalanina e intermediarios del mismo
SE0103046D0 (sv) Kristallin bas av citalopram
ECSP066760A (es) Derivado de 4-oxopirimidina de anillos condensados
CO5721006A2 (es) Derivados de pirazolo-quinazolina, proceso para su preparacion y su uso como inhibidores de quinasa
AR041724A1 (es) Compuestos derivados de fenetanolamina y su utilizacion en composiciones farmaceuticas
UA92083C2 (ru) Азабициклические алкановые производные, замещенные конденсированным бициклогетероциклом
WO2004013120A8 (en) Novel benzodioxoles
EA200101077A1 (ru) Композиция для профилактики или лечения слабоумия, включающая производное гидроксикоричной кислоты или экстракт растения рода angelicae, содержащий его
WO2005066167A3 (en) 3-quinuclidinyl heteroatom bridged biaryl derivatives
EP1679069A4 (en) NEW PIPERIDINE DERIVATIVE
MX2019012336A (es) Compuestos inhibidores del transportador vesicular de monoaminas 2 (vmat2) y composiciones de los mismos.
ATE460394T1 (de) 5-asa-derivate mit entzündungshemmender und antibiotischer wirkung und verfahren zur behandlung von krankheiten mit diesen derivaten
WO2021046523A8 (en) Composition of matter for use in organic light-emitting diodes
AR035728A1 (es) Proceso perfeccionado para la sintesis de carbapenem
ECSP055865A (es) Perindopril
PL366905A1 (en) Crystalline forms of fluvastatin sodium
MXPA03011954A (es) Nuevos derivados de acido sulfonico.
BRPI0409105A (pt) análogos de quinobenzoxazina substituìdos
ATE332304T1 (de) Cefdinir salze als zwischenprodukte
BR0212899A (pt) Compostos orgânicos
EE04345B1 (et) Simvastatiini ja selle derivaatide valmistamise protsess
TW200510356A (en) Benzoxaepine compounds
SA522441473B1 (ar) Cdk7 مركبات مفيدة لتثبيط
HRP20080262T3 (hr) Derivati 4-(2-feniloksifenil)-piperidin ili -1,2,3,6 tetrahidropiridin kao inhibitori ponovne apsorpcije serotonina
CO5700712A2 (es) Prevencion y tratamiento de la enfermedad de alzheimer

Legal Events

Date Code Title Description
FG Grant, registration
FG Grant, registration